Literature DB >> 19341789

Peptide-mediated DNA condensation for non-viral gene therapy.

Paolo Saccardo1, Antonio Villaverde, Nuria González-Montalbán.   

Abstract

The construction of non-viral, virus-like vehicles for gene therapy involves the functionalization of multipartite constructs with nucleic acid-binding, cationic agents. Short basic peptides, alone or as fusion proteins, are appropriate DNA binding and condensing elements, whose incorporation into gene delivery vehicles results in the formation of protein-DNA complexes of appropriate size for cell internalization and intracellular trafficking. We review here the most used cationic peptides for artificial virus construction as well as the recently implemented strategies to control the architecture and biological activities of the resulting nanosized particles.

Mesh:

Substances:

Year:  2009        PMID: 19341789     DOI: 10.1016/j.biotechadv.2009.03.004

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  14 in total

1.  Direct observation of dynamic mechanical regulation of DNA condensation by environmental stimuli.

Authors:  Amy Lee; Adam Karcz; Ryan Akman; Tai Zheng; Sara Kwon; Szu-Ting Chou; Sarah Sucayan; Lucas J Tricoli; Jason M Hustedt; Qixin Leng; Jason D Kahn; A James Mixson; Joonil Seog
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-21       Impact factor: 15.336

2.  DNA Condensation with a Boron-Containing Cationic Peptide for Modeling Boron Neutron Capture Therapy.

Authors:  Chris C Perry; Jose Ramos-Méndez; Jamie R Milligan
Journal:  Radiat Phys Chem Oxf Engl 1993       Date:  2019-10-10       Impact factor: 2.858

3.  Engineering building blocks for self-assembling protein nanoparticles.

Authors:  Esther Vázquez; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2010-12-30       Impact factor: 5.328

4.  Amino Acid Sequence of Oligopeptide Causes Marked Difference in DNA Compaction and Transcription.

Authors:  Anatoly Zinchenko; Hiroyuki Hiramatsu; Hideaki Yamaguchi; Koji Kubo; Shizuaki Murata; Toshio Kanbe; Norio Hazemoto; Kenichi Yoshikawa; Tatsuo Akitaya
Journal:  Biophys J       Date:  2019-04-19       Impact factor: 4.033

Review 5.  Novel delivery approaches for cancer therapeutics.

Authors:  Ashim K Mitra; Vibhuti Agrahari; Abhirup Mandal; Kishore Cholkar; Chandramouli Natarajan; Sujay Shah; Mary Joseph; Hoang M Trinh; Ravi Vaishya; Xiaoyan Yang; Yi Hao; Varun Khurana; Dhananjay Pal
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 6.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

7.  Cholesterol-peptide hybrids to form liposome-like vesicles for gene delivery.

Authors:  Qiong Tang; Bin Cao; Haiyan Wu; Gang Cheng
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

8.  Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery.

Authors:  Arvind K Jain; Ashley Massey; Helmy Yusuf; Denise M McDonald; Helen O McCarthy; Vicky L Kett
Journal:  Int J Nanomedicine       Date:  2015-11-24

9.  Chitosan combined with poly-L-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA delivery.

Authors:  Samarwadee Plianwong; Praneet Opanasopit; Tanasait Ngawhirunpat; Theerasak Rojanarata
Journal:  Biomed Res Int       Date:  2013-06-23       Impact factor: 3.411

10.  Selective condensation of DNA by aminoglycoside antibiotics.

Authors:  M Kopaczynska; A Schulz; K Fraczkowska; S Kraszewski; H Podbielska; J H Fuhrhop
Journal:  Eur Biophys J       Date:  2015-12-08       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.